EHSI: Report Predicts Home-Based Telemedical Devices to Top 2 Million by 2013

Emerging Healthcare Solutions, Inc. (Pink Sheets:EHSI) applauded the results of a new report from InMedica on the world market for telemedicine, predicting that the use of home-based medical devices will drastically increase as telemedicine takes-off. According to the report, by 2013 the combined unit shipments of home-use digital blood-glucose meters, blood pressure monitors, weight scales, pulse oximeters and peak flow meters used in telemedical applications will grow to over 1.6 million. Shipments of health hubs will also increase, such that the total shipments of telemedical devices will top 2 million. InMedica is the medical research division of IMS Research.

The Company sees this report as good news for their new MedAnywhere iPhone app project, which is currently being developed. An increasing market for home-based patient monitoring equipment is expected to bolster the power of the company’s MedAnywhere app, once development is completed. The MedAnywhere iPhone app is being configured to potentially accommodate a very wide variety of home-based patient monitoring equipment.

EHSI took the lead in the new mobile Telemedicine industry through their prior licensing and development of an extraordinary mobile cellular-based communications platform for ambulances. This system was originally the brainchild of Dr. Red Duke and was funded through a $20 million US Department of Defense grant to the University of Texas Health Sciences Center at Houston. UT then engaged Texas A&M to fully develop the system.

The iPhone is a portable data device produced by Apple, Inc. (NASDAQ:AAPL). Emerging Healthcare Solutions focuses on the development of emerging medical technology, a sector that also includes the Laboratory Corporation of America (NYSE:LH), Covance Inc. (NYSE:CVD) and Inverness medical Innovations Inc. (NYSE:IMA).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. is a medical technology company that works to bring new and innovative medical technologies to the market. The Company’s model is to engage a technology prior to its inflection point in order to maximize the profits available to EHSI as that new technology is adopted. Our common stock is traded under the symbol EHSI.

For more information, visit http://www.emerginghealthcaresolutionsinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.

Contacts:

Emerging Healthcare Solutions, Inc.
Kathy Delaney, 713-821-1486

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.